Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens

被引:33
作者
Kim, S. -H. [1 ]
Kee, S. Y. [2 ]
Lee, D. -G. [3 ,4 ]
Choi, S. -M. [3 ]
Park, S. H. [3 ]
Kwon, J. -C. [5 ]
Eom, K. -S. [3 ,4 ]
Kim, Y. -J. [3 ,4 ]
Kim, H. -J. [3 ,4 ]
Lee, S. [3 ,4 ]
Min, C. -K. [3 ,4 ]
Kim, D. -W. [3 ,4 ]
Choi, J. -H. [3 ]
Yoo, J. -H. [3 ]
Lee, J. -W. [3 ,4 ]
Min, W. -S. [3 ,4 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea
[2] Konkuk Univ, Sch Med, Dept Internal Med, Chungju, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 150173, South Korea
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul 150173, South Korea
[5] Natl Hlth Insurance Corp, Ilsan Hosp, Dept Internal Med, Div Infect Dis, Goyang Si, Gyeonggi Do, South Korea
关键词
infection; allogeneic stem cell transplantation; transplantation conditioning; mortality; SINGLE-CENTER EXPERIENCE; VERSUS-HOST-DISEASE; WORKING-PARTY AGIHO; NEUTROPENIC PATIENTS; CYTOMEGALOVIRUS-INFECTION; IMMUNOLOGICAL RECOVERY; HEMORRHAGIC CYSTITIS; BACTERIAL-INFECTION; MATCHED CONTROL; ONCOLOGY DGHO;
D O I
10.1111/tid.12003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. In allogeneic stem cell transplantation (allo-SCT), reduced-intensity conditioning (RIC) is known for producing less regimen-related toxicity. However, whether or not RIC reduces the risk for infection and infection-related mortality (IRM) remains controversial. Methods. We retrospectively analyzed infectious episodes and IRMs after allo-SCTs by time period and by the intensity of the conditioning regimen (RIC [n = 81] vs. myeloablative conditioning, MAC [n = 150]). Results. The cumulative incidence of any kind of infection was lower in the RIC group through the entire period (72% vs. 87%; P = 0.007). The onset of infections was deferred in the RIC group as compared with the MAC group (P = 0.012). Bacteremia occurred less frequently in the RIC group through the entire period (5% vs. 14%; P = 0.044). However, the incidences of cytomegalovirus reactivation and disease, herpes zoster, virus-associated hemorrhagic cystitis, and invasive fungal infection were not different between the two groups. Furthermore, there was no difference in relapse-free survival and IRM between the two conditioning regimens. Conclusion. Careful monitoring and appropriate preventive/therapeutic strategies for infectious complications, comparable to those for allo-SCT recipients with MAC, should also be applied to those with RIC, especially after engraftment.
引用
收藏
页码:49 / 59
页数:11
相关论文
共 37 条
[11]   Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation [J].
Hori, A ;
Kami, M ;
Kim, SW ;
Chizuka, A ;
Kojima, R ;
Imataki, O ;
Sakiyama, M ;
Hamaki, T ;
Onishi, Y ;
Usubuchi, N ;
Kisbi, Y ;
Murashige, N ;
Tajima, K ;
Miyakoshi, S ;
Heike, Y ;
Masuo, S ;
Taniguchi, S ;
Takaue, Y .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (01) :65-72
[12]   EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF FEBRILE EPISODES IN NEUTROPENIC PATIENTS [J].
HUGHES, WT ;
PIZZO, PA ;
WADE, JC ;
ARMSTRONG, D ;
WEBB, CD ;
YOUNG, LS .
CLINICAL INFECTIOUS DISEASES, 1992, 15 :S206-S215
[13]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[14]   Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study [J].
Junghanss, C ;
Marr, KA ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Chauncey, T ;
McSweeney, PA ;
Storb, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) :512-520
[15]   Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study [J].
Junghanss, C ;
Boeckh, M ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Chauncey, T ;
McSweeney, PA ;
Little, MT ;
Corey, L ;
Storb, R .
BLOOD, 2002, 99 (06) :1978-1985
[16]   Chronic graft-versus-host disease [J].
Lee, SJ ;
Vogelsang, G ;
Flowers, MED .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (04) :215-233
[17]   Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm [J].
Leung, AYH ;
Yuen, KY ;
Kwong, YL .
BONE MARROW TRANSPLANTATION, 2005, 36 (11) :929-937
[18]   Antimicrobial therapy of unexplained fever in neutropenic patients -: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society) [J].
Link, H ;
Böhme, A ;
Cornely, OA ;
Höffken, K ;
Kellner, O ;
Kern, WV ;
Mahlberg, R ;
Maschmeyer, G ;
Nowrousian, MR ;
Ostermann, H ;
Ruhnke, M ;
Sezer, O ;
Schiel, X ;
Wilhelm, M ;
Auner, HW .
ANNALS OF HEMATOLOGY, 2003, 82 (Suppl 2) :S105-S117
[19]   Definitions of cytomegalovirus infection and disease in transplant recipients [J].
Ljungman, P ;
Griffiths, P ;
Paya, C .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1094-1097
[20]   Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS [J].
Luger, S. M. ;
Ringden, O. ;
Zhang, M-J ;
Perez, W. S. ;
Bishop, M. R. ;
Bornhauser, M. ;
Bredeson, C. N. ;
Cairo, M. S. ;
Copelan, E. A. ;
Gale, R. P. ;
Giralt, S. A. ;
Gulbas, Z. ;
Gupta, V. ;
Hale, G. A. ;
Lazarus, H. M. ;
Lewis, V. A. ;
Lill, M. C. ;
McCarthy, P. L. ;
Weisdorf, D. J. ;
Pulsipher, M. A. .
BONE MARROW TRANSPLANTATION, 2012, 47 (02) :203-211